TMPRSS4 and breast cancer: The antineoplastic effects of quercetin (corresponding dose of 1311 mg/g per 16 weeks for a man of 60 Kg of BW [114]) have also been described in another mouse model of BC, i.e., in C3(1)/SV40 Tag mice, which displayed a quercetin-induced reduction in tumor volume, as well as revealing a decreased expression of transmembrane protease serine 4, a known marker of poor prognosis for BC [114,115].